These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21138144)

  • 41. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
    Kauffmann DJ; van Meurs JC; Mertens DA; Peperkamp E; Master C; Gerritsen ME
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
    Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
    Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema.
    Shimada H; Akaza E; Yuzawa M; Kawashima M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2953-5. PubMed ID: 19060271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy.
    Ma Y; Tao Y; Lu Q; Jiang YR
    Am J Ophthalmol; 2011 Oct; 152(4):678-685.e2. PubMed ID: 21704966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitreous inflammatory factors and macular oedema.
    Funatsu H; Noma H; Mimura T; Eguchi S
    Br J Ophthalmol; 2012 Feb; 96(2):302-4. PubMed ID: 20860986
    [No Abstract]   [Full Text] [Related]  

  • 48. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Kanda A; Noda K; Saito W; Ishida S
    Br J Ophthalmol; 2013 May; 97(5):666-8. PubMed ID: 23418197
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity.
    Simó R; Lecube A; García-Arumí J; Carrasco E; Hernández C
    Diabetes Care; 2004 Jan; 27(1):287-8. PubMed ID: 14694016
    [No Abstract]   [Full Text] [Related]  

  • 50. Increased intravitreal adenosine 5'-triphosphate, adenosine 5'-diphosphate and adenosine 5'-monophosphate levels in patients with proliferative diabetic retinopathy.
    Loukovaara S; Sahanne S; Jalkanen S; Yegutkin GG
    Acta Ophthalmol; 2015 Feb; 93(1):67-73. PubMed ID: 25079888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous.
    Maier R; Weger M; Haller-Schober EM; El-Shabrawi Y; Theisl A; Barth A; Aigner R; Haas A
    Mol Vis; 2006 Oct; 12():1143-7. PubMed ID: 17093399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitreous levels of vascular endothelial growth factor-B in proliferative diabetic retinopathy.
    Kinoshita S; Noda K; Saito W; Kanda A; Ishida S
    Acta Ophthalmol; 2016 Sep; 94(6):e521-3. PubMed ID: 26826065
    [No Abstract]   [Full Text] [Related]  

  • 53. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
    Malik RA; Li C; Aziz W; Olson JA; Vohra A; McHardy KC; Forrester JV; Boulton AJ; Wilson PB; Liu D; McLeod D; Kumar S
    J Cell Mol Med; 2005; 9(3):692-7. PubMed ID: 16202216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placenta growth factor and vascular endothelial growth factor in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Tashimo A; Ohtsuka K; Mizue Y; Nishihira J
    Clin Exp Ophthalmol; 2005 Apr; 33(2):226-7. PubMed ID: 15807839
    [No Abstract]   [Full Text] [Related]  

  • 55. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
    Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
    Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association of serum and vitreous adropin concentrations with diabetic retinopathy.
    Li S; Sun J; Hu W; Liu Y; Lin D; Duan H; Liu F
    Ann Clin Biochem; 2019 Mar; 56(2):253-258. PubMed ID: 30514096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of cytokines in diabetic retinopathy.
    Ideta R; Yamashita H; Tanaka Y; Kato S; Kitano S; Hori S
    Arch Ophthalmol; 1999 May; 117(5):700-1. PubMed ID: 10326979
    [No Abstract]   [Full Text] [Related]  

  • 58. A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy.
    Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K
    Endokrynol Pol; 2008; 59(1):2-5. PubMed ID: 18335393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Sato H; Abe T; Wakusawa R; Asai N; Kunikata H; Ohta H; Sonoda H; Sato Y; Nishida K
    Diabetologia; 2009 Feb; 52(2):359-61. PubMed ID: 19057892
    [No Abstract]   [Full Text] [Related]  

  • 60. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy.
    Katsura Y; Okano T; Matsuno K; Osako M; Kure M; Watanabe T; Iwaki Y; Noritake M; Kosano H; Nishigori H; Matsuoka T
    Diabetes Care; 2005 Sep; 28(9):2252-4. PubMed ID: 16123502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.